Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) mortality rates have not shown significant reduction in decades. Platelets are being implicated in having cancer-promoting roles, an observation supported by the adverse outcomes associated with thrombocytosis in many malignancies associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Rachidi, Saleh, Wallace, Kristin, Day, Terry A, Alberg, Anthony J, Li, Zihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189675/
https://www.ncbi.nlm.nih.gov/pubmed/25260646
http://dx.doi.org/10.1186/s13045-014-0065-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189675/
https://www.ncbi.nlm.nih.gov/pubmed/25260646
http://dx.doi.org/10.1186/s13045-014-0065-5

Ejemplares similares